Suchergebnisse - "Benelli, Matteo"

PubPharm (8)

1

Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib : Results From the TREnd Trial

enthalten in: JCO precision oncology | 2024

von Migliaccio, I. | Romagnoli, D. | Galardi, F. | +12

2

Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Malorni, L. | Tyekucheva, S. | Hilbers, F. | +32

3

Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von De Angelis, C. | Fu, X. | Cataldo, M. | +27

ErratumIn: Clin Cancer Res. 2021 Sep 1;27(17):4939. - PMID 34470810

4

Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer : results from a translational sub-study of the TREnd trial

enthalten in: Breast cancer research : BCR | 2021

von Galardi, F. | De Luca, F. | Biagioni, C. | +16

5

Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von McCartney, A. | Bonechi, M. | De Luca, F. | +14

6

Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib

enthalten in: Cells | 2020

von Lorito, N. | Bacci, M. | Smiriglia, A. | +11

7

Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial

enthalten in: Breast cancer research : BCR | 2019

von Rossi, L. | Biagioni, C. | McCartney, A. | +17

8

Mechanisms of Resistance to CDK4/6 Inhibitors : Potential Implications and Biomarkers for Clinical Practice

enthalten in: Frontiers in oncology | 2019

von McCartney, A. | Migliaccio, I. | Bonechi, M. | +9

1
[1]